BACKGROUND: Direct reprogramming of fibroblasts to cardiomyocytes is a potentially curative strategy for ischemic heart ...

The Medical City (TMC) has earned a spot in Newsweek and Statista’s 2025 list of top-performing hospitals across the Asia ...

For younger acute myocardial infarction (AMI) survivors, living in marginalized neighborhoods is associated with adverse ...

Secondary analysis findings from the EMPACT-MI trial highlight empagliflozin's significant cardiovascular and kidney benefits when initiated soon after an acute myocardial infarction.

The triggering receptor expressed on myeloid cells 2 (TREM2) plays a pivotal role in the activation of myeloid cells and is currently being investigated as a potential therapeutic target in several ...

Women who developed a cardiovascular disease or type 2 diabetes were at a higher risk of developing breast cancer post ...

For patients with acute MI at increased risk for HF, empagliflozin showed cardiorenal benefits and was safe to initiate early ...

The FDA expanded the indication for finerenone (Kerendia) in heart failure (HF), drug manufacturer Bayer announced.

Treating coronary artery disease patients with monotherapy using clopidogrel or ticagrelor was associated with lower rates of ...

A secondary analysis of a large trial shows that exposure to the HIV drug abacavir is linked to an elevated risk for major ...

In recent months, Karnataka has witnessed a disturbing rise in sudden cardiac deaths among young individuals—many of them ...

For younger acute myocardial infarction (AMI) survivors, living in marginalized neighborhoods is associated with adverse ...